Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03455400
Other study ID # EETTMK:104/2017
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 5, 2018
Est. completion date August 31, 2018

Study information

Verified date April 2020
Source University of Oulu
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Electrical impedance tomography (EIT) is an evolving monitoring tool for respiratory support in neonatal and pediatric intensive care. In this observational study basic EIT parameters will be measured on 20 healthy newborn infants during spontaneous breathing and assess the effect of position changes in ventilation distribution.


Description:

NEO SensorBelts will be used to observe ventilation distribution in healthy newborn infants during quiet spontaneous breathing. Child's position will be changed 5 times every 10 minutes in a random order. Positions observed will be: left lateral, right lateral, supine, prone face to left, prone face to right and supine with the bed tilted 30 degrees. Total duration for the recording will be 1 hour.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date August 31, 2018
Est. primary completion date August 31, 2018
Accepts healthy volunteers No
Gender All
Age group N/A to 5 Days
Eligibility Inclusion Criteria:

- Written informed consent from a parent or legal guardian

- Gestational age 37+0 - 42+0 weeks

- Uneventful follow-up in maternity ward

Exclusion Criteria:

- Respiratory distress

- Admission to NICU

- Thorax skin lesions

- Prior participation in this study

Study Design


Intervention

Device:
Swisstom BB2 EIT device
Swisstom BB2 EIT device with NEO SensorBelts will be used to measure ventilation distribution during spontaneous breathing and position changes in healthy newborn infants.

Locations

Country Name City State
Finland Oulu University Hospital Oulu

Sponsors (1)

Lead Sponsor Collaborator
University of Oulu

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anteroposterior ventilation distribution The ventral-to-dorsal center of ventilation will be calculated as described in (Frerichs et al., Acta AnaesthesiolScand. 1998; 42:721-726) as a value between 0 and 100%, higher values indicating a more dorsal distribution of ventilation. 1 hour
Primary Right-to-left ventilation distribution Changes in right-to-left ventilation distribution following position changes will be calculated 1 hour
See also
  Status Clinical Trial Phase
Completed NCT05420649 - Evaluation of the Feasibility and Safety of Laryngoscopic Microsurgery Under Non-intubation Anesthesia N/A